Clinical Chemistry And Immunoassay Industry Forecast Report To 2028: Integrated And Scalable Core Lab Solutions Driving Transformational Growth


(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The "Clinical Chemistry and Immunoassay Industry, Global, 2023-2028" report has been added to ResearchAndMarkets.com's offering.
This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to support the diagnosis and treatment of human health.
While clinical chemistry instruments and tests target different chemicals in body fluids to evaluate health and the clinical management of patients, immunoassay instruments and tests measure the presence or concentration of analytes in biological liquid by using the binding of antibodies to antigens to identify and measure certain substances. This competitive analysis examines IVD companies that provide a broad menu of clinical chemistry and immunoassay systems, including instruments and consumables.

Key end-user verticals comprise hospitals, clinics, diagnostic laboratories, and research institutions. The sector is segmented by applications, including cancer/oncology, cardiac, diabetes, infectious, and others, for market revenue estimations and forecasts. The study also identifies four growth opportunities that build on trends, maximize the economic potential, and sustain value.

Key Growth Opportunities

  • Sepsis IVDs
  • Neurology IVDs
  • Routine Testing
  • Integrated Analyzers

Key Topics Covered:

Growth Environment: Transformation in the Clinical Chemistry and Immunoassay Sector

  • The Impact of the Top 3 Strategic Imperatives on the Clinical Chemistry and Immunoassay Industry

Clinical Chemistry and Immunoassay Sector Ecosystem

  • Competitive Environment
  • Key Competitors

Growth Generator: Clinical Chemistry and Immunoassay Sector

  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Considerations
  • Revenue Forecast
  • Revenue Forecast by Application Areas
  • Revenue Forecast by Region
  • Revenue Forecast Analysis
  • Pricing Trends and Forecast Analysis
  • Revenue Share
  • Revenue Share Analysis

Growth Generator: Cancer

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Generator: Cardiac

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Generator: Diabetes

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Generator: Infectious Diseases

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Generator: Others

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Appendix & Next Steps

  • Benefits and Impacts of Growth Opportunities

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN17122024004107003653ID1109003910


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.